Cryoablation Device for Benign Breat Tumors
Mon, 10/13/2008 - 11:20am
The Visica 2™ Treatment System is a minimally invasive cryotechnology device that is FDA cleared for the treatment of fibroadenomas, a common benign breast condition found in at least 10 percent of all women in the United States. The procedure uses cryoablation, or extreme cold, to destroy tumors without requiring stitches or general anesthesia. The office-based procedure, which usually takes less than 30 minutes, involves placing a small needle into the center of the tumor using ultrasound guidance. The System creates very cold temperatures at the needle tip, freezing the fibroadenoma, damaging the tumor cells and causing them to break down to prevent re-growth.